citalopram has been researched along with Cerebral Infarction in 2 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to investigate whether the routine administration of escitalopram for three months would improve the prognosis of patients with ischemic stroke and decrease the plasma copeptin level." | 9.34 | Effects of the prophylactic use of escitalopram on the prognosis and the plasma copeptin level in patients with acute cerebral infarction. ( Cao, JX; Chen, JC; Liu, L; Sun, YT; Wang, Y; Zeng, QH, 2020) |
| "This study aims to investigate the effects of escitalopram on neural functional prognoses and endothelial dysfunction after acute ischemic stroke." | 9.34 | Escitalopram improves neural functional prognosis and endothelial dysfunction in patients with acute cerebral infarction. ( Cao, JX; Chen, JC; Liu, L; Sun, YT; Yang, ZD; Zeng, QH, 2020) |
| "This study aimed to investigate whether the routine administration of escitalopram for three months would improve the prognosis of patients with ischemic stroke and decrease the plasma copeptin level." | 5.34 | Effects of the prophylactic use of escitalopram on the prognosis and the plasma copeptin level in patients with acute cerebral infarction. ( Cao, JX; Chen, JC; Liu, L; Sun, YT; Wang, Y; Zeng, QH, 2020) |
| "This study aims to investigate the effects of escitalopram on neural functional prognoses and endothelial dysfunction after acute ischemic stroke." | 5.34 | Escitalopram improves neural functional prognosis and endothelial dysfunction in patients with acute cerebral infarction. ( Cao, JX; Chen, JC; Liu, L; Sun, YT; Yang, ZD; Zeng, QH, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, JX | 2 |
| Liu, L | 2 |
| Sun, YT | 2 |
| Zeng, QH | 2 |
| Wang, Y | 1 |
| Chen, JC | 2 |
| Yang, ZD | 1 |
2 trials available for citalopram and Cerebral Infarction
| Article | Year |
|---|---|
Effects of the prophylactic use of escitalopram on the prognosis and the plasma copeptin level in patients with acute cerebral infarction.
Topics: Acute Disease; Brain Ischemia; Cerebral Infarction; Citalopram; Humans; Stroke; United States | 2020 |
Escitalopram improves neural functional prognosis and endothelial dysfunction in patients with acute cerebral infarction.
Topics: Acute Disease; Aged; Cerebral Infarction; Citalopram; Endothelium, Vascular; Female; Humans; Ischemi | 2020 |